PATENT CLAIM ANALYSIS

Application Number: 15974293
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["424", "001690"]

Abstract:
Provided are fragments of human p97 (melanotransferrin) polypeptides having blood-brain barrier (BBB) transport activity, including variants and combinations thereof, conjugates comprising said p97 fragments, and related methods of use thereof, for instance, to facilitate delivery of therapeutic or diagnostic agents across the BBB.

Claim (Index 62):
The method of  claim 61  wherein the p97 fragment consists of DSSHAFTLDELR (SEQ ID NO: 13) with a C-terminal tyrosine, and wherein the p97 fragment and the active agent are separated by a peptide linker of about 1-10 amino acids in length.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 93.0
- Lexical Diversity: 1.325
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15153074', '14210029', '14226506', '13566260', '13542435']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7571776902242957
- 35 USC 102 Novelty (BERT): 0.6178375546213826
- Combined Prediction Score: 0.7432436766640044
- Mean Citation Score: 461.51006000000007
- Max Citation Score: 610.91254
- Similarity Product: 474.7040655829525

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test